SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
961 87 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
886$GILD out at $106.7 and $4000 profit since I started day trading in October so hSybilNicolas-11/25/2015
885$GILD looks range bound. Sell Iron condors at the 101/112 rangeSybilNicolas-11/24/2015
884The new Moderator of Silicon Investor's main Gilead Science board in now SybSI Dmitry (code monkey)-11/17/2015
883Also added today - a tad earlier at $110.65.Paul Senior-8/21/2015
882I also just averaged up at $106.80.Labrador-8/21/2015
881Averaging up on my GILD with some buys now.Paul Senior-8/13/2015
880I added to my GILD position today as stock comes down a little. Analysts stillPaul Senior-11/21/2014
879These guys need to use that code evolved from Codexis (CDXS). That will def boosLivinin703-11/4/2014
878Gilead Sciences Inc S&P Capital IQ October 28,2014 Fair Value Calculation $mobile_moment-10/30/2014
877* Gilead Sciences GILD.O : Credit Suisse raises price target to $130 from $110; checkmate-10/29/2014
876Barron's Take Gilead: Buy the Dip Shares are down on mixed quarterly resultmobile_moment-10/29/2014
875Gilead's Hep C Combo Pill Harvoni Approved, Priced By Amy Reeves, Investor&#vitalremains-10/11/2014
874Dear Gilead Science participants, This board could use a Moderator (and logo), SI Dmitry (code monkey)-10/10/2014
873approval w/ 8 week. looks good.mopgcw-10/10/2014
8727% gilead.com seekingalpha.comDanD-9/19/2014
871Not publicly disclosed.DewDiligence_on_SI-9/16/2014
870How will ABBV/ENTA's drug/regimen affect GILD's drug sales/profits in 20DewDiligence_on_SI-9/16/2014
869Anyone know the licensing rate/royalty?DanD-9/16/2014
868Which leads me to ask: How will ABBV/ENTA's drug/regimen affect GILD'sPaul Senior-9/13/2014
867Hi Paul, My opinion of their drugs in the pipeline being "promising" kbullick-9/13/2014
866...competitor drugs won't arrive on scene until at least very late 2015.ThatDewDiligence_on_SI19/13/2014
865 I also feel that their other drugs appear to be promising as well. I want to knPaul Senior-9/13/2014
864Thanks for your reply!! This is exactly why I wrote. I was hoping that I mightkbullick-9/12/2014
863No need to worry—Sovaldi is not going generic! Rather, GILD is licensing SovaldiDewDiligence_on_SI-9/12/2014
862Hi, I was watching Gilead all the way back in April when many biotechs took a hikbullick-9/12/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News